Alex Kentsis, MD, PhD
Affiliations: | Memorial Sloan-Kettering Cancer Center, Rockville Centre, NY, United States |
Area:
Cancer biology, rational therapy, drug designWebsite:
http://alexkentsis.netGoogle:
"Alex Kentsis"Bio:
http://search.proquest.com/docview/305044026
Mean distance: 9.7 | S | N | B | C | P |
Parents
Sign in to add mentor| Tobin R. Sosnick | grad student | 1994-1998 | Chicago | |
| (M.S.) | ||||
| Katherine L.B. Borden | grad student | 1998-2004 | Mount Sinai School of Medicine | |
| (Self -organization of biological systems: Protein folding and supramolecular assembly.) | ||||
| Roman Osman | grad student | 1998-2004 | Mount Sinai School of Medicine | |
| (Self -organization of biological systems: Protein folding and supramolecular assembly.) | ||||
| Thomas Look | post-doc | 2008-2012 | Dana-Farber Cancer Institute, Children's Hospital Boston, Harvard Medical School | |
Children
Sign in to add trainee| Nicole A. McNeer | post-doc | 2017-2020 | Memorial Sloan Kettering Cancer Center (BME Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fiala EM, Ortiz MV, Kennedy JA, et al. (2020) 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood. Cancer |
| Wan L, Chong S, Xuan F, et al. (2019) Impaired cell fate through gain-of-function mutations in a chromatin reader. Nature |
| Ortiz MV, Ahmed S, Burns M, et al. (2019) Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor. Jci Insight. 4 |
| Sher F, Hossain M, Seruggia D, et al. (2019) Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis. Nature Genetics |
| MacArthur IC, Bei Y, Dorado García H, et al. (2019) Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma. Jci Insight. 5 |
| McNeer NA, Philip J, Geiger H, et al. (2019) Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia. Leukemia |
| McNeer N, Philip J, Geiger H, et al. (2019) Abstract 2870: Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia Cancer Research |
| Henssen AG, Kentsis A. (2018) Emerging functions of DNA transposases and oncogenic mutators in childhood cancer development. Jci Insight. 3 |
| Cifani P, Dhabaria A, Chen Z, et al. (2018) ProteomeGenerator: A framework for comprehensive proteomics based on de novo transcriptome assembly and high-accuracy peptide mass spectral matching. Journal of Proteome Research |
| Johnson DC, Taabazuing CY, Okondo MC, et al. (2018) DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nature Medicine |